KYTH

Kythera Biopharmaceuticals, Inc. News Headlines

$20.95
*  
0.05
  negative  
0.24%
Get KYTH Alerts
*Delayed - data as of May 22, 2013 14:17 ET 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
View:    KYTH Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

KYTHERA Biopharma To Present At Bank Of America Conference; Webcast At 2:20 PM
5/14/2013 1:20:00 PM - RTT News

Bearish MACD for Kythera Biopharmaceuticals Inc. - Tale of the Tape
4/24/2013 12:14:00 PM - Zacks.com

Kythera Presents Positive MRI Results From Phase IIb Study Of ATX-101 In SMF
4/13/2013 6:51:00 PM - RTT News

KYTHERA Announces Positive Interim Results From Phase IIIb Study Of ATX-101
4/6/2013 12:52:00 PM - RTT News

Is Kythera's Double Chin Drug A Winner?
4/2/2013 7:57:00 PM - Seeking Alpha

ALIM To Be Eyed, Big News At Titan, MusclePharm Strengthens
3/21/2013 10:20:00 PM - RTT News

Kythera Biopharma Q4 Loss Widens
3/21/2013 5:37:00 PM - RTT News

Gilead Hits 52-Week High - Analyst Blog
3/13/2013 10:12:09 AM - Zacks.com

CBST Gets Global Rights to Antibiotic Candidate - Analyst Blog
3/12/2013 6:12:34 PM - Zacks.com

Encouraging Data Presented by Gilead - Analyst Blog
3/12/2013 2:31:01 PM - Zacks.com

Good News for Gilead's HIV Pipeline - Analyst Blog
3/7/2013 2:40:01 PM - Zacks.com

KYTHERA Biopharma To Present At Cowen & Co. Conference; Webcast At 11:20 AM ET
3/5/2013 10:20:00 AM - RTT News

Celgene's Apremilast Encourages - Analyst Blog
3/4/2013 2:30:01 PM - Zacks.com

KYTH Talks Of Double Chin Fix, REGN's Skin Care Works, IMUN Gives Up On ITL Suit
3/3/2013 10:14:00 PM - RTT News

KYTHERA Announces Positive Interim Results From Open-Label Study Of ATX-101
3/2/2013 11:09:00 AM - RTT News

Medivation Beats 4Q Expectations - Analyst Blog
3/1/2013 10:00:01 AM - Zacks.com

KYTHERA Biopharma To Present At RBC Global Conference; Webcast At 10:00 AM
2/26/2013 9:00:00 AM - RTT News

Bayer Presents Positive ATX101 Data - Analyst Blog
2/5/2013 6:20:01 PM - Zacks.com

Cramer's Mad Money - What Makes An IPO Successful? (10/15/12)
10/16/2012 4:08:00 AM - Seeking Alpha

Kythera Biopharmaceuticals: Successful Offering Of This One-Drug Company Backed By Bayer
10/15/2012 7:34:00 AM - Seeking Alpha

KYTHERA Biopharma prices upsized deal at $16, at high end of the range
10/11/2012 8:36:12 AM - Renaissance Capital

Shutterstock prices IPO at $17, above the range
10/10/2012 10:16:42 PM - Renaissance Capital

IPO Preview: KYTHERA Biopharmaceuticals
10/10/2012 3:48:00 PM - Seeking Alpha

What To Know Before IPOs Pick Back Up
10/9/2012 11:50:00 AM - Seeking Alpha

Last Week In Global IPOs: Strong U.S. Deal Flow Set To Continue
10/9/2012 11:48:00 AM - Seeking Alpha